Contribute
España
Italia
대한민국
日本
Français
Benzinga
Research
My Stocks
Tools
Free Benzinga Pro Trial
SPY
762.980.17%
QQQ
722.050.08%
BTC/USD
80479.900.9192%
DIA
516.150.05%
GLD
401.490.08%
TLT
81.260.01%

Propanc Biopharma Inc (PPCB) Stock Price, Quote, News & History

PPCBNASDAQ
Trade with Public
Trade with Public
$0.6100
-0.02-3.17%
At close: Sep 18, 5:00 PM EST
$0.6093
-0.0007-0.11%
After Hours: Sep 18, 6:48 PM EST
OverviewNewsEarnings ForecastFinancialsSentimentCompareStock Report

Propanc Biopharma (PPCB) Stock Price, Quote, News & History | Benzinga

Key Statistics

Open
$0.66
Close
$0.61
Volume / Avg.
160.54K / 2.69M
Day Range
$0.60 - $0.67
52 Wk Range
0.63 - 60.00
Market Cap
$1.39M
P/E Ratio
0.00
Dividend Yield
-
Exchange
NASDAQ
RSI
36
Short Interest
16.47%
Days to Cover
1

Recent Propanc Biopharma Inc News

Why Elastic Shares Are Trading Higher By 22%; Here Are 20 Stocks Moving Premarket

Elastic NV (ESTC) stock rose 21.8% in pre-market trading after reporting strong Q1 results and raising FY27 guidance. Other top gainers include WHLR, QNRX, AEMD, NA, SOLS, HYNE, GAP, AFRM, and ARKR. Top losers are BTAI, LGPS, FGL, HCWC, and KTCC.
Avi Kapoor

Crude Oil Moves Higher; Dollar General Shares Gain After Upbeat Q2 Earnings

U.S. stocks traded higher, Dow up 0.20%, NASDAQ up 1.05%, S&P 500 up 0.47%. Tech shares jumped 2.4% while consumer staples fell 1%. Dollar General gained 5% on strong earnings. Propanc Biopharma soared 157%. Okta and Veeva Systems also rose. Build-A-Bear Workshop and Healthequity fell on earnings. European and Asian markets closed mostly lower.
Avi Kapoor

Revolution Medicines’ Pancreatic Cancer Drug Approval Validates Microcap Propanc Biopharma’s Breakthrough Survival Results

Propanc Biopharma reports strong preclinical data from pancreatic cancer drug, PRP, showing over 90% tumor inhibition and extended survival.
Vandana Singh

Nasdaq Surges 200 Points; Nvidia Posts Upbeat Q2 Results

US stocks traded higher with Nasdaq up 200 points. Dow down 0.01%, Nasdaq up 0.77%, and S&P 500 up 0.27%. Tech shares rose 2.2% while consumer staples fell 1.1%. Nvidia reported strong earnings. Propanc Biopharma up 211%, VolitionRX up 86%, Mint Incorporation up 74%, Alpha Modus down 25%, Change Agents down 29%, and Xiao-I down 21%.
Avi Kapoor

Why Friedman Industries Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket

Friedman Industries Inc (NASDAQ: FRD) rose in pre-market trading after posting strong Q4 earnings. Other gainers include BYAH, VSME, ADTX, EDHL, GMM, HKIT, RKTO, ASYS, and PWRL. Losers include GELS, NTCL, ZNB, SMSI, and NEPT.
Avi Kapoor
60%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-4.17M
Investing Cash Flow (TTM)
-
Financing Cash Flow (TTM)
4.55M
Free Cash Flow (TTM)
-4.18M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
368.49K

Valuation Metrics

Enterprise Value
$2.51M
PE Ratio (TTM)
0.00
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
0.15
Earnings Yield % (TTM)
90555.56%
Earnings Yield % (FWD)
-
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$4.31

Company Debt

Total Debt
$520.28K
LT Debt
-
LT Debt Issuance (TTM)
$77.55K
LT Debt Repayment (TTM)
-
Total Cash
$443.70K
Debt to Equity
0.06
Issuance of Debt (TTM)
-$91.65K
Repayment of Debt (TTM)
-$1.07M

Key Statistics

Open
$0.66
Close
$0.61
Volume / Avg.
160.54K / 2.69M
Day Range
$0.60 - $0.67
52 Wk Range
0.63 - 60.00
Market Cap
$1.39M
P/E Ratio
0.00
Dividend Yield
-
Exchange
NASDAQ
RSI
36
Short Interest
16.47%
Days to Cover
1

About

Sector
Health Care
Industry
Biotechnology
Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Propanc Biopharma (PPCB) stock?

A

You can purchase shares of Propanc Biopharma (NASDAQ:PPCB) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Propanc Biopharma (PPCB) competitors?

Q

What is the forecast, or price target, for Propanc Biopharma (PPCB) stock?

A

There is no analysis for Propanc Biopharma to provide a consensus price target.

Q

What is the current price for Propanc Biopharma (PPCB)?

A

The stock price for Propanc Biopharma (NASDAQ: PPCB) is $0.6093 last updated September 18, 2026 at 6:48 PM EDT.

Q

Does Propanc Biopharma (PPCB) pay a dividend?

A

There are no upcoming dividends for Propanc Biopharma.

Q

When is Propanc Biopharma (NASDAQ:PPCB) reporting earnings?

A

Propanc Biopharma does not have any upcoming earnings scheduled.

Q

Is Propanc Biopharma (PPCB) going to split?

A

There is no upcoming split for Propanc Biopharma.

Q

What sector and industry does Propanc Biopharma (PPCB) operate in?

A

Propanc Biopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved